Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Value in Health ; 25(7):S452-S453, 2022.
Article in English | EMBASE | ID: covidwho-1926723

ABSTRACT

Objective: Colombia has an expanded program of immunization of >22 biologics mainly for younger than 6 years old. We aimed to estimate vaccination coverage in children under 6 years old in San Jacinto (Bolivar), in a post-conflict and COVID-19 pandemic scenario. Methods: We conducted a cross-sectional survey from October to November of 2021, in a Caribbean municipality of Colombia (24,910 population) mostly affected by the armed conflict. A two-stage cluster sampling was used with a precision of 5.5% and a design effect of 2, considering a non-response rate of 20%. We collected data on immunization record cards and other basic sociodemographic information from surveys of caregivers of children. Absolute and timely-vaccine coverages adjusted by age were estimated. Data analysis was performed in Stata 13. Results: Out of 187 surveyed children, 159 (85.3%) had vaccination card. BCG (tuberculosis) vaccine had the greater coverage (99,3%), followed by Hb, pentavalent, and polio (>98%). All biologics showed absolute coverages greater than 90%, except for yellow fever (82.6%) and 5-year boosters (70% for MMR [measles, mumps, rubella] booster and 73% for polio and DPT booster). Age-appropriate timely vaccination coverages were lower than absolutes for all biologics. BCG and hepatitis B had coverages of 97% and initial doses of pentavalent, pneumococcal, polio, MMR, and first and second doses of rotavirus reported coverages greater than 91%. Second and third or booster dosages of pentavalent, polio, pneumococcal and booster of DPT, polio, and MMR had coverages between 70-80%. Lowest timely vaccination coverage were yellow fever (2.3%) and influenza (42.8% for first and 26.5% for second dosage). Conclusion: Although most vaccination coverages were greater than 90%, probably the mobility restrictions due to the pandemic severely impacted the timing of vaccination. Other plausible reasons are the timely flow of vaccines (opportunity in administration and vaccine shortages).

SELECTION OF CITATIONS
SEARCH DETAIL